Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Expression of tumour necrosis factor receptors by bronchoalveolar cells in hypersensitivity pneumonitis.

Authors: Chen, B  Tong, Z  Ye, Q  Nakamura, S  Costabel, U  Guzman, J 
Citation: Chen B, etal., Eur Respir J. 2005 Jun;25(6):1039-43.
Pubmed: (View Article at PubMed) PMID:15929959
DOI: Full-text: DOI:10.1183/09031936.05.00084704

Tumour necrosis factor receptors (TNFR) and the Fas receptor (FasR) have been implicated in the pathogenesis of interstitial lung diseases. The current authors examined the expression of TNFR-1, TNFR-2 and FasR by bronchoalveolar cells in hypersensitivity pneumonitis (HP). Cell surface receptor expression on bronchoalveolar lavage cells was analysed by immunocytochemistry in 11 HP patients, 11 idiopathic pulmonary fibrosis (IPF) patients and 10 controls. TNFR-1, TNFR-2 and FasR were expressed on a higher percentage of alveolar macrophages (AM) in HP compared with controls and IPF patients. TNFR-2 and FasR expression on lymphocytes was also higher in HP than in controls and in IPF. TNFR-1, TNFR-2 and FasR expression correlated positively with the percentage of lymphocytes, and negatively with the percentage of AM in HP. Expression of TNFR-1 on AM and TNFR-2 on lymphocytes correlated with the percentage of neutrophils in HP. In conclusion, this study shows evidence of altered expression of tumour necrosis factor superfamily receptors in hypersensitivity pneumonitis.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 5131148
Created: 2011-04-20
Species: All species
Last Modified: 2011-04-20
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.